share_log

Alexander & Baldwin Analyst Ratings

Benzinga Analyst Ratings ·  Oct 7, 2022 07:42
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/07/2022 14.45% Piper Sandler $22 → $20 Maintains Overweight
07/30/2021 25.89% Piper Sandler $20 → $22 Upgrades Neutral → Overweight
02/27/2020 25.89% Piper Sandler $23 → $22 Maintains Neutral
02/20/2018 JMP Securities Upgrades Market Perform → Market Outperform

Alexander & Baldwin Questions & Answers

What is the target price for Alexander & Baldwin (ALEX)?

The latest price target for Alexander & Baldwin (NYSE: ALEX) was reported by Piper Sandler on October 7, 2022. The analyst firm set a price target for $20.00 expecting ALEX to rise to within 12 months (a possible 14.45% upside). 1 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Alexander & Baldwin (ALEX)?

The latest analyst rating for Alexander & Baldwin (NYSE: ALEX) was provided by Piper Sandler, and Alexander & Baldwin maintained their overweight rating.

When is the next analyst rating going to be posted or updated for Alexander & Baldwin (ALEX)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alexander & Baldwin, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alexander & Baldwin was filed on October 7, 2022 so you should expect the next rating to be made available sometime around October 7, 2023.

Is the Analyst Rating Alexander & Baldwin (ALEX) correct?

While ratings are subjective and will change, the latest Alexander & Baldwin (ALEX) rating was a maintained with a price target of $22.00 to $20.00. The current price Alexander & Baldwin (ALEX) is trading at is $17.48, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment